| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.25 | 0.1 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.084 | 0.1 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |